Electromed (ELMD) Tops Q3 EPS by 2c

Electromed (NYSE: ELMD) reported Q3 EPS of $0.12, $0.02 better than the analyst estimate of $0.10. Revenue for the quarter came in at $12.1 million versus the consensus estimate of $12.05 million.

For earnings history and earnings-related data on Electromed (ELMD) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c